Loading...

Rainmed Medical Limited

2297.HKHKSE
HealthcareMedical - Devices
$0.16
$0.00(0.00%)

Rainmed Medical Limited (2297.HK) Stock Overview

Explore Rainmed Medical Limited’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for 2297.HKStats details for 2297.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for 2297.HKAnalyst Recommendations details for 2297.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Rainmed Medical Limited, a medical device company, focus on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microvascular resistance systems. The company offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system, which calculates FFR values based on a three-dimensional model of the coronary arterial system restored from two angiograms and FlashAngio caIMR System, a non-invasive microcirculatory lesion diagnosis and treatment system. It is also involved in developing intelligent angiographic injection, flash robot vascular intervention navigation operation system, and flash renal denervation systems. The company was founded in 2014 and is headquartered in Suzhou, China.

CEO

Mr. Yunfei Huo

Employees

270

Headquarters

Building 31, Suzhou

Founded

2022

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.